Nickolas Papadopoulos
Cancer prevention


BS, Aristotle University of Thessaloniki, Thessaloniki, Greece

MS, University of Houston

PhD, University of Texas Health Science Center at Houston

Cancer is a genetic disease, and from all the differences between cancer and normal cells it is the genetic alterations present in the cancer cells that unequivocally distinguish them from the normal cells. Such genetic alterations provide exquisite specificity as biomarkers and pinpoint targets for the development of therapeutics. Our group has focused on: a) applying genome-wide approaches, such as high-throughput, massively parallel sequencing, for the identification of genetic changes on specific genes involved in the development and progression of cancer; and b) using this knowledge for the development of clinically applicable methods for early diagnostics, companion diagnostics, monitoring of disease, and therapeutics for cancer.

Ludwig Center at Johns Hopkins
1650 Orleans Street, Cancer Research Building, Room 590
Baltimore, Maryland, U.S. 21287

T 410 955 8878
F 410 955 0548


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?